Sign In
Buy SNGX
$0.362
-0.0003 (-0.0829%)
At Close: Jul 28, 2026
Why Fusion Pharmaceuticals Shares Are Trading Higher By 23%; Here Are 20 Stocks Moving Premarket
12:55pm, Tuesday, 14'th Feb 2023 Benzinga
Gainers
Blue Water Vaccines, Inc. (NASDAQ: BWV) shares rose 38.3% to $1.62 in pre-market trading. Blue Water Vaccines recently appointed Frank Jaeger, seasoned commercial operations and business deve
Soligenix stock slumps as cancer drug application is knocked back
10:44am, Tuesday, 14'th Feb 2023
Soligenix (NASDAQ:SNGX) slumped in Tuesday's early deals after revealing its cancer drug has been knocked back by the US Food and Drug Administration. The company, in a statement, told investors that
Soligenix Invited to Present at the Virtual Investor Summit Event
07:30am, Thursday, 19'th Jan 2023
Focusing on 25 micro-cap companies with key catalysts and/or strong performance in the current market PRINCETON, N.J. , Jan. 19, 2023 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the
Why Shares of Chinese Companies Are Trading Higher? Here Are 55 Stocks Moving In Tuesday's Mid-Day Session
06:27pm, Tuesday, 27'th Dec 2022 Benzinga
Gainers
Elys Game Technology, Corp. (NASDAQ: ELYS) shares jumped 147% to $0.4312. Elys Game Technology and Cloakbook DC have been granted license to open sportsbook in Washington, D.C.
180 Life Scien
Why Tuesday Morning Shares Are Trading Lower By 38%; Here Are 31 Stocks Moving Premarket
11:40am, Tuesday, 27'th Dec 2022 Benzinga
Gainers
Neptune Wellness Solutions Inc. (NASDAQ: NEPT) shares rose 106.9% to $0.5482 in pre-market trading on heavy volume.
HTG Molecular Diagnostics, Inc. (NASDAQ: HTGM) rose 61.6% to $5.01 in pre
7 Stocks to Add to Your 10x Watchlist
12:09pm, Friday, 16'th Dec 2022
There are few things that get growth investors excited like the opportunity to invest in 10x stocks. By definition, these 10x stocks (also referred to as 10 baggers) can add huge gains to your portfol
Investor Summit Group Announces Soligenix, Inc. To Present at Q4 Conference
09:30am, Friday, 11'th Nov 2022
Princeton, New Jersey--(Newsfile Corp. - November 11, 2022) - Investor Summit Group, today announced that Soligenix, Inc. (NASDAQ: SNGX) (Soligenix or the Company) will attend the Q4 Investor Summit l
Soligenix: A Biotech Bargain Ready To File For Approval In Cutaneous T-Cell Lymphoma
09:40am, Wednesday, 05'th Oct 2022
Soligenix is an underfollowed biotech company trading at a $20 million market cap. The company is about to file an NDA for HyBryte, which I expect to become a first-in-class treatment in cutaneous T-c
Soligenix Shares Gain On HyBrytes Data From Blood Cancer Study
03:19pm, Wednesday, 20'th Jul 2022
Soligenix Inc (NASDAQ: SNGX) announced the results of its Phase 3 FLASH study evaluating HyBryte (synthetic hypericin) for cutaneous T-cell lymphoma (CTCL) had been published in the Journal of the
Soligenix's COVID-19 Vaccine Candidate As Booster Neutralizes Delta, Omicron Variants
09:44am, Thursday, 17'th Mar 2022
Soligenix Inc (NASDAQ: SNGX) announced the results of a booster vaccination study using CiVax (heat-stable COVID-19 subunit vaccine program) in non-human primates (NHPs). The data demonstrated ra
Soligenix to Present at the Q1 Virtual Investor Summit
07:30am, Wednesday, 02'nd Mar 2022
PRINCETON, N.J., March 2, 2022 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to t
Soligenix, Inc. to Present at the Q1 Virtual Investor Summit
03:04pm, Tuesday, 01'st Mar 2022
Princeton, New Jersey--(Newsfile Corp. - March 1, 2022) - Soligenix, Inc. (NASDAQ: SNGX) today announced that Jonathan Guarino, Senior Vice President & Chief Financial Officer will be attending the Q1
Soligenix to Present at the 2022 BIO CEO & Investor Conference
07:30am, Tuesday, 08'th Feb 2022
PRINCETON, N.J., Feb. 8, 2022 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to t
Soligenix to Present at Upcoming Investor Conferences
12:30pm, Thursday, 06'th Jan 2022 Business Insider Markets
PRINCETON, N.J., Jan. 6, 2022 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need,
Soligenix to Present at Upcoming Investor Conferences
07:30am, Thursday, 06'th Jan 2022
PRINCETON, N.J., Jan. 6, 2022 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to t
